echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of 2-Chloronicotinamide

    The Synthetic Routes of 2-Chloronicotinamide

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    2-Chloronicotinamide is a versatile chemical compound that is widely used in the pharmaceutical, agricultural, and textile industries.
    It is an important intermediate in the manufacture of several active pharmaceutical ingredients (APIs) and is also used as a herbicide and a fungicide.
    The synthesis of 2-chloronicotinamide can be accomplished through several different routes, each of which has its own advantages and disadvantages.


    One of the most common synthetic routes for 2-chloronicotinamide involves the reaction of cyanamide with nitrochloride in the presence of a Lewis acid catalyst.
    This route is relatively simple and does not require the use of expensive or hazardous reagents.
    The reaction proceeds through the formation of a nitrosonium ion intermediate, which is then reduced to form the desired product.
    This route can be used to produce small quantities of 2-chloronicotinamide for research purposes, but it is not suitable for large-scale production due to the low yield and purity of the product.


    Another synthetic route for 2-chloronicotinamide involves the reaction of ammonia with chloroacetamide in the presence of a mineral acid catalyst.
    This route is more efficient than the previous one and can be used for large-scale production.
    The reaction proceeds through the formation of a diazo compound, which is then reduced to form the desired product.
    This route is more efficient than the previous one, but it still has some disadvantages such as the use of mineral acid which is corrosive and need to be handled with care.


    A more recent and efficient route for the synthesis of 2-chloronicotinamide is the one that uses a microwave-assisted hydrothermal method.
    This route uses aqueous hydrochloric acid as the catalyst and microwave irradiation to accelerate the reaction.
    This route is considered more efficient as it reduces the reaction time, thus saving on energy costs and is less hazardous to handle.
    This route is also very cost-effective as it uses non-expensive reactants and is less prone to produce waste.


    In conclusion, there are several synthetic routes for the production of 2-chloronicotinamide, each with its own advantages and disadvantages.
    The choice of route depends on factors such as the scale of production and the desired purity of the product.
    The microwave-assisted hydrothermal method is considered to be the most efficient and cost-effective route for the synthesis of 2-chloronicotinamide, as it reduces the reaction time and does not require the use of hazardous reagents.
    This route is also more environmentally friendly as it produces less waste and is less prone to produce side products.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.